Search Results - "Dunbar, Erin M"

Phase 1/2 Trials of Temozolomide, Motexafin Gadolinium, and 60-Gy Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme: Final Results of RTOG 0513 by Brachman, David G., MD, Pugh, Stephanie L., PhD, Ashby, Lynn S., MD, Thomas, Theresa A., MS, Dunbar, Erin M., MD, Narayan, Samir, MD, Robins, H. Ian, MD, PhD, Bovi, Joseph A., MD, Rockhill, Jason K., MD, PhD, Won, Minhee, MA, Curran, Walter P., MD

“…Purpose The purpose of phase 1 was to determine the maximum tolerated dose (MTD) of motexafin gadolinium (MGd) given concurrently with temozolomide (TMZ) and…”
Get full text

A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma by Ramesh, Karthik K, Huang, Vicki, Rosenthal, Jeffrey, Mellon, Eric A, Goryawala, Mohammed, Barker, Peter B, Gurbani, Saumya S, Trivedi, Anuradha G, Giuffrida, Alexander S, Schreibmann, Eduard, Han, Hui, de le Fuente, Macarena, Dunbar, Erin M, Holdhoff, Matthias, Kleinberg, Lawrence R, Shu, Hui-Kuo G, Shim, Hyunsuk, Weinberg, Brent D

“…Glioblastoma (GBM) is a fatal disease, with poor prognosis exacerbated by difficulty in assessing tumor extent with imaging. Spectroscopic MRI (sMRI) is a…”
Get full text

The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease by Dunbar, Erin M, Buzzeo, Mathew P, Levine, Jeff B, Schold, Jesse D, Meier-Kriesche, Herwig-Ulf, Reddy, Vijay

“…1 Division of Hematology/Oncology, Department of Medicine, University of Florida, Gainesville, Florida 2 Division of Nephrology, Hypertension and Renal…”
Get full text

Multidisciplinary spine oncology care across the disease continuum by Dunbar, Erin M

Get full text

In pursuit of a perpetually burning flame: preventing burnout in neuro-oncology by Dunbar, Erin M, Kumthekar, Priya U

Get full text

Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells by Ross, Heather H., Rahman, Maryam, Levkoff, Lindsay H., Millette, Sebastien, Martin-Carreras, Teresa, Dunbar, Erin M., Reynolds, Brent A., Laywell, Eric D.

Get full text

Unexpectedly durable palliation of metastatic olfactory neuroblastoma using anti-angiogenic therapy with Bevacizumab by Dunbar, Erin M, Pumphrey, Phyllis K, Bidari, Sharat

“…Olfactory neuroblastomas (ONBs) are rare malignant tumors that arise from olfactory epithelium and typically present with symptoms attributable to locally…”
Get full text

Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients by Ranjan, Surabhi, Leung, Denise, Ghiaseddin, Ashley P., Taylor, Jennie W., Lobbous, Mina, Dhawan, Andrew, Budhu, Joshua A., Coffee, Elizabeth, Melnick, Kaitlyn, Chowdhary, Sajeel A., Lu‐Emerson, Christine, Kurz, Sylvia C., Burke, Joy E., Lam, Keng, Patel, Mallika P., Dunbar, Erin M., Mohile, Nimish A., Peters, Katherine B.

“…Management of venous thromboembolism (VTE) in patients with primary and metastatic brain tumors (BT) is challenging because of the risk of intracranial…”
Get full text

A broad perspective on evaluating bias in the neuro-oncology workplace by Kumthekar, Priya, Dunbar, Erin M, Peters, Katherine B, Brastianos, Priscilla K, Porter, Alyx B

Get full text

Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma by Karajannis, Matthias A, Mauguen, Audrey, Maloku, Ekrem, Xu, Qingwen, Dunbar, Erin M, Plotkin, Scott R, Yaffee, Anna, Wang, Shiyang, Roland, J Thomas, Sen, Chandranath, Placantonakis, Dimitris G, Golfinos, John G, Allen, Jeffrey C, Vitanza, Nicholas A, Chiriboga, Luis A, Schneider, Robert J, Deng, Jingjing, Neubert, Thomas A, Goldberg, Judith D, Zagzag, David, Giancotti, Filippo G, Blakeley, Jaishri O

“…Inhibition of mTORC1 signaling has been shown to diminish growth of meningiomas and schwannomas in preclinical studies, and clinical data suggest that…”
Get full text

Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors by Rogers, James L., Wall, Thomas, Acquaye-Mallory, Alvina A., Boris, Lisa, Kim, Yeonju, Aldape, Kenneth, Quezado, Martha M., Butman, John A., Smirniotopoulos, James G., Chaudhry, Huma, Tsien, Christina I., Chittiboina, Prashant, Zaghloul, Kareem, Aboud, Orwa, Avgeropoulos, Nicholas G., Burton, Eric C., Cachia, David M., Dixit, Karan S., Drappatz, Jan, Dunbar, Erin M., Forsyth, Peter, Komlodi-Pasztor, Edina, Mandel, Jacob, Ozer, Byram H., Lee, Eudocia Q., Ranjan, Surabhi, Lukas, Rimas V., Raygada, Margarita, Salacz, Michael E., Smith-Cohn, Matthew A., Snyder, James, Soldatos, Ariane, Theeler, Brett J., Widemann, Brigitte C., Camphausen, Kevin A., Heiss, John D., Armstrong, Terri S., Gilbert, Mark R., Penas-Prado, Marta

“…Purpose Multidisciplinary tumor boards (MTBs) integrate clinical, molecular, and radiological information and facilitate coordination of neuro-oncology care…”
Get full text

A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma by Ramesh, Karthik, Mellon, Eric A, Gurbani, Saumya S, Weinberg, Brent D, Schreibmann, Eduard, Sheriff, Sulaiman A, Goryawala, Mohammed, de le Fuente, Macarena, Eaton, Bree R, Zhong, Jim, Voloschin, Alfredo D, Sengupta, Soma, Dunbar, Erin M, Holdhoff, Matthias, Barker, Peter B, Maudsley, Andrew A, Kleinberg, Lawrence R, Shim, Hyunsuk, Shu, Hui-Kuo G

“…Abstract Background Glioblastomas (GBMs) are aggressive brain tumors despite radiation therapy (RT) to 60 Gy and temozolomide (TMZ). Spectroscopic magnetic…”
Get full text

Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05) by Swinnen, Lode J, O'Neill, Anne, Imus, Philip H, Gujar, Sachin, Schiff, David, Kleinberg, Lawrence R, Advani, Ranjana H, Dunbar, Erin M, Moore, Dennis, Grossman, Stuart A

“…Therapy of primary CNS lymphoma (PCNSL) has focused on multi-agent chemotherapy designed to cross the blood brain barrier. Rituximab has demonstrated activity…”
Get full text

Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells by Ross, Heather H., Rahman, Maryam, Levkoff, Lindsay H., Millette, Sebastien, Martin-Carreras, Teresa, Dunbar, Erin M., Reynolds, Brent A., Laywell, Eric D.

“…Thymidine analogs (TAs) are synthetic nucleosides that incorporate into newly synthesized DNA. Halogenated pyrimidines (HPs), such as bromodeoxyuridine (BrdU),…”
Get full text

Practical guidance for telemedicine use in neuro-oncology by Strowd, Roy E, Dunbar, Erin M, Gan, Hui K, Kurz, Sylvia, Jordan, Justin T, Mandel, Jacob J, Mohile, Nimish A, Nevel, Kathryn S, Taylor, Jennie W, Ullrich, Nicole J, Welch, Mary R, Wasilewski, Andrea, Mrugala, Maciej M

“…Abstract While the COVID-19 pandemic has catalyzed the expansion of telemedicine into nearly every specialty of medicine, few articles have summarized current…”
Get full text

Modern Multidisciplinary Management of Brain Metastases by Thomas, Sajeve S., Dunbar, Erin M.

“…Ideal management of brain metastases (BMs) requires simultaneous control of the existing brain metastasis (local brain control), prevention of future BMs…”
Get full text

The future of glioma treatment: stem cells, nanotechnology and personalized medicine by Rahman, Maryam, Hoh, Brian, Kohler, Nathan, Dunbar, Erin M, Murad, Gregory J A

“…The development of novel therapies, imaging techniques and insights into the processes that drive growth of CNS tumors have allowed growing enthusiasm for the…”
Get more information

Genetic counseling and tumor predisposition in neuro-oncology practice by Dunbar, Erin M., Eppolito, Amanda, Henson, John W.

“…Tumor predisposition syndromes may be under-recognized in neuro-oncology practice. Identifying patients with a hereditary tumor predisposition permits…”
Get full text

Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) by Leeper, Heather E, Tonorezos, Emily, Mayer, Deborah, Bakitas, Marie, Chang, Susan, Cooley, Mary E, Hervey-Jumper, Shawn, Miaskowski, Christine, Sherwood, Paula, Tsien, Christina, Wallgren, Kimberly, Willmarth, Nicole, Arons, David, Acquaye, Alvina, King, Amanda L, Penas-Prado, Marta, Vera, Elizabeth, Gilbert, Mark R, Armstrong, Terri S

“…Abstract Background Survivorship for those living with primary CNS cancers begins at diagnosis, continues throughout a person’s life, and includes caregivers…”
Get full text

The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment by Mrugala, Maciej M, Ostrom, Quinn T, Pressley, Shelley M, Taylor, Jennie W, Thomas, Alissa A, Wefel, Jeffrey S, Coven, Scott L, Acquaye, Alvina A, Haynes, Chas, Agnihotri, Sameer, Lim, Michael, Peters, Katherine B, Sulman, Erik P, Salcido, Joanne T, Butowski, Nicholas A, Hervey-Jumper, Shawn, Mansouri, Alireza, Oliver, Kathy R, Porter, Alyx B, Nassiri, Farshad, Schiff, David, Dunbar, Erin M, Hegi, Monika E, Armstrong, Terri S, van den Bent, Martin J, Chang, Susan M, Zadeh, Gelareh, Chheda, Milan G

“…Abstract Background It remains unknown how the COVID-19 pandemic has changed neuro-oncology clinical practice, training, and research efforts. Methods We…”
Get full text